Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diyu shengbai
- Development stage
- Unknown
- Lead developer
- Chengdu Diao Tianfu Pharmaceutical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Diyu Shengbai (地榆升白) is a Traditional Chinese Medicine (TCM) product, most commonly available as Diyu Shengbai Tablets, derived from the root of *Sanguisorba officinalis* (Great Burnet). It is officially approved in China for the treatment of leukopenia, particularly when induced by radiotherapy, chemotherapy, or benzene poisoning. The therapeutic effect is attributed to its ability to promote the proliferation and differentiation of hematopoietic stem cells in the bone marrow, thereby increasing peripheral white blood cell counts. Beyond its hematological applications, clinical research, such as that conducted by Renmin Hospital of Wuhan University, is exploring its role in mitigating ischemia-reperfusion injury (IRI) in renal transplant patients by regulating metabolic pathways and reducing oxidative stress.
- Brand names
- Diyu Shengbai TabletsDiyu Shengbai Pian
- Other names
- Sanguisorba officinalis extract
Beyond the preview
Go deeper on diyu shengbai.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diyu shengbai.